Introduction
During the past few years a growing number of investigators have suggested that FSH, in addition to its stimulatory influence on the seminiferous tubules (Sertoli cells) may also exert effects on Leydig cell steroidogenic function. This consideration has largely been prompted by the finding that FSH treatment of hypophysectomized rats results in an increase in the maximum quantity of LH-stimulated androgen secretion by Leydig cells, both in vivo (Odell & Swerdloff, 1975; Selin & Moger, 1977) and in vitro (Chen, Payne & Kelch, 1976; van Beurden, Roodnat, de Jong, Mulder & van der Molen, 1976; Chen, Shaw & Payne, 1977) . Furthermore, FSH also appears to stimulate the number of LH receptors in testis tissue (Chen et al, 1977) . However, interpretation of these apparent effects of FSH is made difficult in light of the fact that the Leydig cell does not possess FSH receptors (de Kretser, Catt & Paulsen, 1971) and in addition that all of the currently available FSH preparations are contaminated to various degrees with LH.
There are two major aims of the present study: (1) to confirm the stimulatory influence of FSH on Leydig cell function in the hypophysectomized immature rat, and (2) to determine whether this influence could be partly or wholly explained by contamination of the hormone preparation with small quantities of LH.
Materials and Methods Animals and treatments
Immature male rats, hypophysectomized on Day 29 after birth, were purchased from Hormone Assay Laboratory, Chicago. Hormone treatments began immediately on the day of arrival (Day 31), 2 days after hypophysectomy. Study 1. Hypophysectomized rats (50) were divided equally into 5 groups and treated with the following: Group A (controls), saline (9 g NaCl/1); Group B, 50 (LER-1881) . All preparations were administered as described in Study 1.
Treatment with LH antiserum
The LH antiserum was raised against oLH in rabbits and 50 ul of this serum neutralized 10 µg NIH-LH-S18. Details concerning the monospecificity of this antiserum are presented elsewhere (Madhwa Raj & Moudgal, 1970) . Since most NIH-FSH preparations have LH contamination of <1% it was assumed that the 50 µg oFSH dose contained less than 0-5 µg contaminating LH. The freeze-dried oFSH (10 mg) was first dissolved in 500 µ phosphatebuffered saune (PBS), pH 7-4, and then divided into equal volumes. One half was incubated with 250 ul LH antiserum at 4°C for 3 h whilst the remaining half was incubated under identical conditions with the same volume of normal rabbit serum. After incubation, the LH-antibody complexes were precipitated by centrifugation (4000 g, 10 min) and the supernatants were then diluted with PBS containing 0-1% bovine serum albumin (BSA) to give a final concentration of 50 µg oFSH/0-1 ml. It was assumed that no loss of FSH had occurred during the incubation. In the case of the antibody-treated oLH, the volume of antiserum was adjusted to neutralize all of the LH activity in the preparation (1 ml antiserum incubated with 200 µg oLH in 0-1 ml).
Choice of hormone doses to be injected Ovine FSH was administered at a dose level (50 µg/injection) which had earlier been shown to elicit a half-maximal response from the Sertoli cell (androgen-binding protein secretion) in vivo under similar conditions (Hansson et al, 1976b Sand & Torjesen, 1973 for details)) was iodinated by using the sodium hypochlorite method (Redshaw & Lynch, 1974) , and when 20 000 c.p.m. 125I-labelled hLH were exposed to an excess of testicular particles (27 000 g pellet of testis homogenate), approximately 60-70% of the tracer was specifically bound.
In-vitro assay ofLeydig cell-stimulating activity of the hormone preparations
To assess the LH activity of the different hormone preparations an aliquot of the solutions to be injected was added in different dilutions to a Leydig cell suspension prepared from normal 30-day-old rats. The incubations were performed in triplicate at 34°C for 3 h in a shaking incubator in 95% 02:5% C02. The quantity of androgen produced by the Leydig cells in response to the different preparations was determined as described below. On this occasion the number of Leydig cells present in each incubation tube was not determined and the response was simply expressed in terms of androgen produced per flask.
Measurement ofepididymal androgen-binding protein (ABP)
The epididymides were removed from each animal, defatted, pooled and weighed. A cytosol was then prepared from an homogenate of the pooled organs and subjected to polyacrylamide gel electrophoresis in triplicate for the measurement of ABP. The details of this technique have been published elsewhere (Ritzén, French, Weddington, Nayfeh & Hansson, 1974; Purvis & Hansson, 1978) .
Assay ofandrogen
The steroidogenic response was evaluated by measuring the production of 17ß-hydroxyandrogen. A previous study (Purvis et al, 1978b) showed that the steroid secreted by Leydig cells from immature intact and short-term hypophysectomized male rats is predomi¬ nantly 5a-androstane-3a,17ß-diol and not testosterone. The measurement of 17ß-hydroxyandrogens therefore involved the determination not only of testosterone but also the 5a-reduced androgens, 5a-androstane-3ß,17ß-diol and dihydrotestosterone. (1976) showed that continuous administration of the expected contaminating amount of oLH (600 ng/day) in the oFSH preparation had no effect on the in-vitro response of Leydig cells from immature, hypophysectomized rats to LH nor did it increase the effect observed with a supposedly pure rat FSH preparation (containing <0·1% LH). Apart from the fact that the dose of LH administered was lower, it may be significant that the preparation was injected daily and not, as in our case, twice daily. The possibility that such small doses of LH are rapidly metabolized (unless some degree of protection is conferred on it by being injected as a contaminant in a much larger quantity of FSH) is very real, and multiple injections may be necessary to achieve an adequate blood level of LH. The rats were also hypophysectomized at an earlier age (21-25 days) than the present study; this is a critical period for Leydig cell development and these small differences in age may therefore be important. Selin & Moger (1977) (Purvis et al, 1978b) . Indeed, it has long been recognized that several of the major steroidogenic enzymes in the Leydig cell are under LH control (Samuels & Helmreich, 1956; Menon, Dorfman & Forchielli, 1967; Shikita & Hall, 1967; Purvis et al, 1973) and it is therefore not surprising that exposure to low doses of this hormone may have beneficial effects. On the other hand, higher doses of LH may be inhibitory and cause an attenuated response from the Leydig cell (Tsuruhara, Dufau, Cigorraga & Catt, 1977; Purvis, Torjesen, Haug & Hansson, 1977; Purvis et al, 1978b; Sharpe & McNeilly, 1978) . This desensitization phenomenon is now becoming increasingly accepted as a physiological process by which the target tissue can adjust its responsiveness depending on the levels of trophic hormone. It therefore becomes important to distinguish between priming doses of LH and the higher doses which are responsible for these negative effects. Chen et al (1977) have shown that FSH treatment increases the number of LH receptors in testis tissue from hypophysectomized rats, but we could not confirm this observation in the present study. Chen et al (1977) 
